Reprogramming genetic circuits for enhanced NK cell functionality using non-viral precision genome editing (#169)

12:00 PM

Rih-Sheng Huang

NK cells in the Clinic II

Mass Cytometry and Functional Analysis of NK cells on CTN-1101 Trial to Determine the Impact of Graft Source on Immune Reconstitution With Focus on Relapse Protection and Overall Survival (#140)

4:45 PM

Peter Hinderlie

Poster Session One

Engineering Natural Killer Cells to Secrete Engager Molecules Targeting B7-H3 (#250)

8:00 PM

Nicholas A Zorko

Poster Session Two

Uncovering Mechanisms of Enhanced NK Cytotoxicity in the Ovarian Cancer Microenvironment: Molecular Interactions and Therapeutic Potential (#233)

8:00 PM

Terran D Stenger

Poster Session Two

Dual antigen targeting using novel modular TriKE-PACCs enhances NK cell-mediated killing of AML cells (#194)

8:00 PM

Anders W Matson

Poster Session Two

Title: Phase I Study of iPSC derived CAR-NK FT596 with Rituximab as Relapse Prevention After Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) for B-Cell Lymphoma (NCT04555811) (#170)

2:30 PM

Veronika Bachanova

Lightning Session One